BILLERICA, Mass., Dec. 16, 2016 /PRNewswire/ -- Bruker today
announced that it has acquired Active Spectrum
Inc. in Foster
City, California, the inventor and manufacturer of
innovative benchtop micro-ESR (Electron Spin Resonance)
spectroscopy systems used for chemistry teaching and research, as
well as for applied and industrial applications. Financial
terms of the acquisition were not disclosed.
The compact and fully integrated micro-ESR systems developed by
Active Spectrum expand Bruker's existing research and high-end
ESR product line with unique, robust and
easy-to-use benchtop discrete sample or on-line ESR systems, with
remarkably good performance.
Active Spectrum's micro-ESR systems will be integrated into
Bruker's ESR/EPR portfolio and distributed via Bruker's global
sales, service and channel partner network into applied, industrial
and education markets.
ESR is used for the detection of paramagnetic species, and its
applications include the analysis of petroleum and lubricants,
industrial sensing applications that include the detection of
reactive oxygen and nitrogen species. In addition, micro-ESRs are
excellent teaching tools and can be used for undergraduate
chemistry research.
Dr. Iris Mangelschots, President
of the Bruker BioSpin Applied, Industrial & Clinical Division,
stated: "With this acquisition, Bruker has strengthened its
expertise and leadership in benchtop and on-line ESR. Active
Spectrum's unique, performance-leading micro-ESR systems offer an
outstanding platform to develop tailored solutions for the
industrial and applied markets using very compact magnetic
resonance technology."
James R. White, Ph.D., President
and Co-Founder of Active Spectrum Inc., commented: "I am delighted
that Bruker, a leader in magnetic resonance known for innovation
and dedication to excellence, has acquired our micro-ESR
business. We are thrilled that our novel and innovative
approach to this technology has been recognized and adopted by
Bruker. The addition of our micro-ESR systems to their
portfolio will give our customers a wide range of options, backed
by Bruker's global support and service. We are excited to
continue to develop new micro-ESR applications for robust,
effective and affordable benchtop solutions for applied and
industrial markets."
About Active Spectrum
Since its founding in 2005,
Active Spectrum, Inc. has pioneered miniaturized ESR technology for
the measurement of free radicals. Applications include analysis of
petrochemicals additives, crude oil, on-line monitoring of
lubricants, the shelf life of food products and biomedical
research. Active Spectrum's products are used worldwide by both
industry and academia. For further information, visit:
www.activespectrum.com
About Bruker Corporation (NASDAQ: BRKR)
For more than
50 years, Bruker has enabled scientists to make breakthrough
discoveries and develop new applications that improve the quality
of human life. Bruker's high-performance scientific research
instruments and high-value analytical solutions enable scientists
to explore life and materials at molecular, cellular and
microscopic levels. In close cooperation with our customers, Bruker
is enabling innovation, productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics. For more
information: www.bruker.com/ESR
Investor contact:
|
Media contact
(Bruker):
|
Miroslava
Minkova
|
Dr. Thorsten
Thiel
|
Head of Investor
Relations
|
Head of Group
Marketing
|
Bruker
Corporation
|
Bruker BioSpin
Group
|
T: +1 (978) 663-3660,
ext. 1479
|
T: +49 (0)721 – 5161,
ext. 6500
|
E:
Miroslava.Minkova@bruker.com
|
E:
thorsten.thiel@bruker.com
|
|
|
Media contact
(Active Spectrum):
|
|
James
White
|
|
Active Spectrum,
Inc.
|
|
E:
jwhite@activespectrum.com
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bruker-announces-acquisition-of-active-spectrum-micro-esr-business-300379631.html
SOURCE Bruker Corporation